Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors

Toby Trahair^*, Andrew J. Gifford, Ashleigh Fordham, Chelsea Mayoh, Mitali Fadia, Robyn Lukeis, Andrew C. Wood, Santosh Valvi, Roderick D. Walker, James Blackburn, Erin E. Heyer, Tim R. Mercer, Draga Barbaric, Glenn M. Marshall, Karen L. MacKenzie

^*Corresponding author for this work